Skip to main content
OpenTrials
Completed

NCT Number: NCT00156468

Office-Based Asthma Screening Intervention

In prior work, we found that even children who have been seen by their physicians within the prior six months were frequently misclassified as having mild rather than persistent asthma. This study evaluations whether systematic office-based screening assists primary care physicians in identifying children with significant asthma and improves preventive care for asthma. We hypothesize that standardized screening in the office setting will improve the physician's ability to (a) identify children with significant asthma and (b) prescribe appropriate preventive medications.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

2 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Rochester

Rochester, New York, 14642, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children ages 2-12
  • Children arriving for an office visit in two Rochester, NY pediatric clinics
  • Children with a prior diagnosis of asthma AND an exacerbation of symptoms within the previous 2 years

Exclusion criteria

  • Children arriving at the office visit with an adult that is not their parent or guardian
  • Children arriving at the office visit with a parent or guardian that does not speak English
  • Children with other medical conditions making the assessment of asthma severity difficult (cystic fibrosis, heart conditions, etc.)

Treatment and study plan

Provider Prompt

Behavioral

Primary outcomes

  1. "Preventive Medication Actions (PMA)" taken by the provider at the time of the child's visit. A "PMA" is defined as a new medication prescription or change in medication dose.

Secondary outcomes

  1. Alternate actions taken by the provider such as: discussion of environmental controls, medication refills, etc.

Sponsors and collaborators

Lead sponsor

University of Rochester

Other

Collaborators

  • Halcyon Hill Foundation
  • Robert Wood Johnson Foundation

Registry information

Important dates

Study start
2003
Study completion
2005
First posted
Sep 12, 2005
Registry last updated
May 12, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.